Alcor News Bulletin
                  Number 26: May 8, 2004


This bulletin is sent via email to anyone who has requested
it. Please do not reply to this message; the news server at
alcornews.org does not receive email. Send any comments,
suggestions, or complaints to the new address that has been
established to deal with human communications:
 Note, this is a .info address, not a
.com or .org address! If you type the URL manually, please
type carefully. Subscribe/unsubscribe information is at the
end of this message. The layout of Alcor News is best viewed
using a monospaced font such as Courier. Contents are
copyright 2004 by Alcor Foundation but permission is granted
to reprint any whole news item, so long as Alcor is credited
as the source and the reprint includes our URL at

                     Authors This Issue:

Jennifer Chapman [JC], Tanya Jones [TJ], Charles Platt, Joe
Waynick [JW]--Mike Perry, editor.


                        In This Issue:

          Two Cases in April
          Technical Case Reports
          Changes in Financial Methodology
          The Retirement of Joe Hovey
          Personal Statements Needed
          Membership Statistics
          Next Board Meeting


                  Two Cases in April

Alcor's patient population has reached 63 with the addition
of two members this month. Both cases originated in Florida
and involved four-day standby efforts.

During the first case, A-1772, Tanya Jones traveled to
Florida to participate. The patient was suffering from
pancreatic cancer (one of the more insidious forms of
cancer), having been diagnosed less than six months earlier.
With the support of his family and physician, the patient
was admitted to a local hospice for care, and the transport
team was able to remain nearby so as to be ready at the time
of pronouncement.

This was the first case in some time that used a team of
Florida paramedics for stabilization and transport. Though
largely unfamiliar with the particulars of cryonics care,
these paramedics had nearly all the skills necessary to
participate. Little training was required, and what little
there was revolved mostly around the details of negotiating
with the family, hospice, and mortuary personnel.
Stabilization procedures included surface cooling,
medication administration, and blood washout.

As our first whole-body case in some time, this patient
received the glycerol perfusion upon reaching Arizona.
Terminal concentrations were reached, and the deeper cooling
proceeded without incident.

Our second Florida patient was a young man admitted to the
hospital for liver problems. His condition was initially
considered to be a side-effect of experimental HIV
medications he was taking, but later determined to be the
result of Hodgkin's disease. Once the diagnosis indicated
the drug protocol was not at fault, his doctors immediately
changed their approach and began treating the underlying
condition. A-1562 was rushed into chemotherapy, but was so
weak that we were uncertain he would survive the treatment.
A standby team was deployed and later sent home when the
patient responded fairly well.

When the initial call came in, we spoke with the hospital
about prompt pronouncement and what aspects of the
stabilization our team would be able to implement. Though
the administrators and legal department were unwilling to
allow us to perform our procedures on site, they did agree
to administer an abbreviated medication protocol and pack
the patient in ice until such time as the release could be
completed. Most of the non-experimental medications would be
provided by their pharmacy and given after pronouncement by
the nurses. These instructions were included in the
patient's chart for later reference.

Unfortunately, the patient's illness was too severe, and his
decline continued. In accordance with his wishes, the
doctors withdrew medication and life support a few days
later. When we heard this would be done, we dispatched the
local paramedics to manage this case; and within 24 hours,
the patient was pronounced.

Given the high infectious status of this patient and the
lack of experience of our paramedics with washout protocols
(and that no Alcor staff was on-site for this case),
transport procedures were limited to surface cooling and
medication support. The patient was shipped to Alcor on the
first available flight and washout was done at Alcor.

Under the circumstances, we expected the cryoprotection to
be problematic due to the lack of field washout. We were
pleasantly surprised to see one of the fastest applications
of the vitrification protocol in the short history of this
procedure being used on patients. Flow rates and pressures
were good, and the uptake of cryoprotectant was notably
uniform. There was good retraction of the brain, and little
edema observed throughout the five-hour procedure.

Both patients have been cooled to liquid nitrogen
temperature. One (the whole body) has been transferred  to
long-term storage as of this writing; transfer of the other
is expected shortly. [TJ]


                  Technical Case Reports

We have completed the format design and internal publication
of the first of our technical case reports. The original
contains highly confidential information, but a public
version, with names of involved parties removed, will be
published in _Cryonics_ magazine, replacing the standard
narrative format.

With the establishment of a format for analysis and
reporting, we expect to compile technical case data on all
cases missing reports. In time, we intend to also go back
and re-examine past cases. Not a new idea, the intention
behind this effort was to assemble the data necessary to
actually compare cryopreservation procedures on an
analytical level.

Though it is difficult to compare preservation methods when
you cannot take tissue samples of the important organs (like
the brain), Research Associate Todd Huffman is working with
other scientists to establish non-invasive criteria. Some of
the elements under investigation are lactic acid and
creatinine kinase levels, and vascular resistance (an idea
of Hugh Hixon's). More sophisticated analysis comparing
cooling rates and ischemic injury is also under development.
These technical reports are intended to cover the good, the
bad, and the ugly of a cryonics case, and to provide a
record of changes in protocols and procedures that occur as
the result of our learning experiences.

In time, enough data will have been assembled to allow us to
compare different transport scenarios and cryoprotection
protocols, and any comprehensive analyses will also be
published in _Cryonics_. [TJ]


               Changes in Financial Methodology

On January 1, 2004, Alcor undertook the daunting task of
reorganizing its financial reporting methodology. While we
continue to use "fund accounting" for the time being, we
have implemented the following enhancements to give us far
more useful accounting data:

1. A new account numbering system for the chart of accounts;
2. Fund consolidation into a single database vs. five
separate databases;
3. Implementation of transaction classing to separate
financial reports;
4. Use of a systematic cost and income allocation formula
for consistency;
5. A detailed transaction entry system to give us far more
granularity in our financial reports;
6. Elimination of General Journal entries for transfer
accounts to provide a better audit trail of inter-fund

These modifications to our accounting system have not been
without some pain during implementation, and as is usually
the case for major change in any environment, it has taken
longer than originally planned.

For the first time in many years, however, Alcor now has
real-time financial data readily available to help us manage
our resources more effectively. We have the ability to
present accurate financial reports at our monthly board
meetings without the inconvenience of working with obsolete
data that result from reports produced several weeks or
months later.

In addition, our real-time financial data vastly improves
our ability to make sound financial decisions in a more
timely fashion. These new capabilities represent a
significant step forward in Alcor's fiscal management. [JW]


             The Retirement of Joseph A. Hovey

We're all a little sad to announce the retirement of Joe
Hovey from the Alcor staff. A suspension member since 1988
and a full time employee since August 1989, Joe has held
many positions with Alcor, including bookkeeper and
information manager, Comptroller, Corporate Secretary and
Treasurer, and Vice President. Prior to joining the Alcor
staff, Joe's employment history included working for big
government (the CIA), big industry (RCA), and several small
companies, mostly in the fields of accounting or computer

Joe has helped Alcor significantly over the years, filling
thankless roles behind the scenes, providing advice and
support to the staff and Board throughout Though he's
officially retiring, we can still look forward to seeing Joe
around the office, as he will be providing some contract
fundraising assistance to the organization in the future.

On behalf of the Alcor staff and Board of Directors, I'd
like to thank Joe for his fifteen years of service and
encourage him to continue attending the parties and events
we hold. [TJ]


                Personal Statements Needed

I'm looking for statements endorsing cryonics, to be
included in a future Alcor handbook and possibly other Alcor
promotional materials.

Personal endorsements are a very effective way to encourage
other people to sign up. Are you willing to donate 10
minutes of your time to write between 250 and 400 words
explaining why you chose cryonics, and why it is important
to you? If so, please send your statement in plain text as
email to:


If possible, please avoid HTML, Word, or other formatting.
Plain text in the body of your email is preferred.

You may remain anonymous if you wish, but please include as
much as possible of the following information:

* Your age when you signed up
* Your age now
* Where you live (approximately)
* Your primary occupation, if any
* Any factors that made you hesitate to sign up
* Any personal benefits you have received from being signed
* What cryonics means to you
* What you hope to achieve ultimately from cryonics
* Any other family members who are signed up

Also please append the following statement: "I affirm that
the text in this email message was written solely by me. I
assign copyright without compensation to Alcor Foundation
for unlimited use of the text to promote cryonics in any
medium throughout the world."

IMPORTANT: If you are willing to provide a photograph, this
will enhance the value of your statement. Digital images
should be no smaller than 400 x 600 pixels and no larger
than 700 x 1000 pixels. Color and grayscale are both
acceptable. If the image originated in color, please do not
convert it to grayscale. If you send an image in JPEG format
(recommended) please use a high-quality compression setting.
Other acceptable formats include PNG, Photoshop, PDF, and
TIFF. GIF and BMP are acceptable only for grayscale images
with a full range of 255 tones. Files originating from
either PC or Mac are acceptable.

Alcor will notify you if your statement will be published.

Your text will not be edited in any way without your

Thank you!

--Charles Platt


                    Membership Statistics

On April 30, 2004 Alcor had 662 members on its Emergency
Responsibility List. Three memberships were approved during
this month, one membership was reinstated, and two
suspensions were performed.  No cancellations occurred.
Overall, there was a net gain of two members this month.
Alcor also has 121 applicants for membership.  There was a
net gain of one applicant in April. [JC]


                    Next Board Meeting

The next Board meeting is scheduled for Saturday, June 5,
2004 at 11:00 AM (PST), also 11:00 AM local Arizona time.

Board meetings are held on the first Saturday of the month
at the Alcor facility (7895 East Acoma Drive in Scottsdale,
AZ). Members are encouraged to attend.

End of Alcor News bulletin #26 dated May 8, 2004.
Distribution: 508 subscribers.

To subscribe to Alcor News, visit www.alcornews.org and
follow instructions on the web site, or send a blank piece
of email to alcornews with the single


in the subject line. You will receive email asking you to
verify your request for Alcor News.

To unsubscribe or change your email address, visit
www.alcornews.org and alter your preferences.